naphthalen-1-yl(3-((4-propoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone

ID: ALA2030074

Chembl Id: CHEMBL2030074

PubChem CID: 60168098

Max Phase: Preclinical

Molecular Formula: C30H29NO3

Molecular Weight: 451.57

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOc1ccc(OCC2Cc3ccccc3CN2C(=O)c2cccc3ccccc23)cc1

Standard InChI:  InChI=1S/C30H29NO3/c1-2-18-33-26-14-16-27(17-15-26)34-21-25-19-23-9-3-4-10-24(23)20-31(25)30(32)29-13-7-11-22-8-5-6-12-28(22)29/h3-17,25H,2,18-21H2,1H3

Standard InChI Key:  HOPZACRLEPBXCZ-UHFFFAOYSA-N

Associated Targets(Human)

NR1D1 Tchem Nuclear receptor subfamily 1 group D member 1 (332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.57Molecular Weight (Monoisotopic): 451.2147AlogP: 6.27#Rotatable Bonds: 7
Polar Surface Area: 38.77Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.45CX LogD: 6.45
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -0.70

References

1. Noel R, Song X, Shin Y, Banerjee S, Kojetin D, Lin L, Ruiz CH, Cameron MD, Burris TP, Kamenecka TM..  (2012)  Synthesis and SAR of tetrahydroisoquinolines as Rev-erbα agonists.,  22  (11): [PMID:22560469] [10.1016/j.bmcl.2012.04.023]
2. Uriz-Huarte A,Date A,Ang H,Ali S,Brady HJM,Fuchter MJ.  (2020)  The transcriptional repressor REV-ERB as a novel target for disease.,  30  (17): [PMID:32738989] [10.1016/j.bmcl.2020.127395]

Source